To biochemically define Lck as a direct target of NFAT2, we continued to perform chromatin immunoprecipitation (ChIP) in primary human CLL cells using a monoclonal antibody against NFAT2 and subsequent quantitative RT-PCR (Fig. 6b and Supplementary Table 3). Here, LCK is linked to B-cell chronic lymphocytic leukemia.